Haight, Barbara R <br/><br/>
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.  [electronic resource] 

 -  Lancet (London, England)  02 2019 
 - 778-790 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(18)32259-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analgesics, Opioid--blood<br/>Buprenorphine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Injections<br/>Male<br/>Middle Aged<br/>Narcotic Antagonists--administration & dosage<br/>Opioid-Related Disorders--drug therapy<br/>Patient Compliance<br/>Patient Satisfaction<br/>United States